Amgen
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $9,866,000 | $9,557,000 | $9,167,000 | $8,149,000 |
Gross Profit | 8,076,000 | 6,475,000 | 6,156,000 | 5,181,000 |
EBITDA | 3,480,000 | 5,913,000 | 3,617,000 | 4,083,000 |
EBIT | 2,173,000 | 4,606,000 | 2,276,000 | 2,696,000 |
Net Income | 1,333,000 | 3,216,000 | 1,432,000 | 1,730,000 |
Net Change In Cash | 9,866,000 | 9,557,000 | 9,167,000 | 8,149,000 |
Free Cash Flow | 961,000 | 4,248,000 | 1,911,000 | 980,000 |
Cash | 9,129,000 | 9,445,000 | 8,028,000 | 8,810,000 |
Basic Shares | 543,000 | 542,000 | 541,000 | 541,000 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $36,751,000 | $33,424,000 | $28,190,000 | $26,323,000 |
Gross Profit | 30,328,000 | 20,566,000 | 19,739,000 | 19,917,000 |
EBITDA | 17,132,999 | 13,356,000 | 7,897,000 | 12,169,000 |
EBIT | 11,753,000 | 7,764,000 | 7,897,000 | 8,752,000 |
Net Income | 7,711,000 | 4,090,000 | 6,717,000 | 6,552,000 |
Net Change In Cash | 36,751,000 | 33,424,000 | 28,190,000 | 26,323,000 |
Cost of Revenue | -360,000 | |||
Free Cash Flow | 8,100,000 | 10,394,000 | 7,359,000 | 8,785,000 |
Cash | 9,129,000 | 11,973,000 | 10,944,000 | 7,629,000 |
Basic Shares | 542,000 | 541,000 | 538,000 | 541,000 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $5.29 |
2025-09-30 | $5.64 |
2025-06-30 | $6.02 |
2025-03-31 | $4.90 |
